rfXcel Corporation, a leading provider of production-proven ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced that AvKARE has purchased rfXcel’s ePedigree Management solution to protect its supply chain from the threat of counterfeit drugs.
Based in Palaski, TN, AvKARE, is a wholesaler/manufacturer of pharmaceutical and disposable medical supplies whose corporate directive is to ship product on time, in time, every time. AvKARE utilizes a warehouse and shipping facility in Pennsylvania, and manufactures generic pharmaceuticals under its own AvKARE label.
To support compliance with existing Pedigree Laws, as well as future compliance with California’s pending 2011 ePedigree and serialization requirements, AvKARE selected rfXcel’s ePedigree Management solution. rfXcel was selected for its proven track record of successful implementations and for the positive endorsements it receives time and time again from its existing customers regarding its delivery performance.
“In our research, the performance track record of rfXcel made it an easy decision to select them as our partner in our corporate growth strategy”, said Troy Mizell, President of AvKARE. “We need a partner that we can trust and, based on our analysis, we’re convinced that rfXcel is that partner”.
“We’re excited about AvKARE’s decision to select rfXcel as their ePedigree Management partner”, said Glenn Abood, rfXcel’s Founder and CEO. “Our company was founded on the principles of providing the most capable and user-friendly product and delivering on our implementation promises. Endorsements such as this help us confirm our progress towards that end”.
